Search Results 981-990 of 21628 for Inhibition

  1. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    proteasome inhibitor (PI) and immunomodulatory therapy (IMiD), and lenalidomide refractory per International Myeloma Working Group (IMWG) guidelines

  2. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

    Participation eligibility · PD-1 / PD-L1 containing checkpoint inhibitor therapy is permitted; · palliative bone-directed radiotherapy is permitted unless ...

  3. Cholinesterase inhibitors. One effect of lost nerve cells is lower levels of a chemical messenger called acetylcholine. This messenger is important for ...

  4. Lack of sleep: Can it make you sick? - Mayo Clinic

    Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Sleep aids: Understand options sold without a ...

  5. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

    Willing to stop use of strong and moderate inducers and/or strong inhibitors of cytochrome P450 3A ≤ 7 days prior to registration. Provide written informed ...

  6. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    ... inhibitor, to determine the MTD of the combination or a tolerated dose that produces substantial pharmacologic inhibition of both targets; Part 3 will ...

  7. Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases - Mayo Clinic

    Planned anti-cytotoxic therapies, other than tyrosine kinase inhibitors or single-agent monoclonal antibody, or FLT-3 inhibitors within 90 days of post ...

  8. Funding - Division of Emergency Medicine Research

    Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (U01NS062835-06), National Institute of Neurological Disorders and Stroke, 05 ...

  9. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

    Require continued treatment with a medication that is known to be a strong inhibitor of CYP3A enzymes. (Treatment with moderate or weak CYP enzyme inhibitors is ...

  10. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Approach to management of coccidioidomycosis in patients receiving inhibitors of tumor necrosis factor-alpha. Infectious Diseases In Clinical Practice. 2017 ...